Geert Maertens

Title: Geert Maertens - Innovator in Cancer Diagnostics

Introduction

Geert Maertens is a distinguished inventor based in Mechelen, Belgium, known for his contributions to the field of cancer diagnostics. His work primarily focuses on identifying microsatellite instability (MSI) and optimizing the processing of nucleic acids from biological samples.

Latest Patents

Geert Maertens holds two significant patents that address critical challenges in cancer detection. The first patent involves a biomarker panel and methods for detecting microsatellite instability in various cancers, including colorectal, gastric, and endometrial tumors. This innovative diagnostic marker panel facilitates the analysis of MSI loci and provides tools for detecting cancers associated with MSI and mismatch repair (MMR) deficiencies.

His second patent centers on improved compositions and methods for isolating nucleic acids from biological samples. These advancements allow for the direct downstream processing of liberated nucleic acids in microfluidic systems. The described methods and kits are invaluable for diagnosing, staging, and characterizing various biological conditions.

Career Highlights

Geert Maertens is currently affiliated with Biocartis NV, where he applies his expertise to push the boundaries of cancer diagnostics. His innovative approaches contribute to the development of more efficient and accurate diagnostic tools that have the potential to enhance patient outcomes.

Collaborations

Throughout his career, Geert has collaborated with notable coworkers such as Bram De Craene and Klaas Decanniere. These partnerships are instrumental in fostering an environment of innovation and advancing research in cancer diagnostics.

Conclusion

Geert Maertens exemplifies the spirit of innovation in the medical field, particularly in cancer detection and diagnostics. His patents and collaborative efforts at Biocartis NV reflect his dedication to improving healthcare through scientific advancements.